Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Myositis as a neuromuscular complication of immune checkpoint inhibitors.

Vermeulen L, Depuydt CE, Weckx P, Bechter O, Van Damme P, Thal DR, Claeys KG.

Acta Neurol Belg. 2020 Apr;120(2):355-364. doi: 10.1007/s13760-020-01282-w. Epub 2020 Jan 29.

PMID:
31993961
2.

Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks.

Depuydt CE, Donders G, Verstraete L, Vanden Broeck D, Beert J, Salembier G, Bosmans E, DhontT N, Van Der Auwera I, Vandenborne K, Ombelet W.

Facts Views Vis Obgyn. 2018 Dec;10(4):201-205.

3.

Infectious human papillomavirus virions in semen reduce clinical pregnancy rates in women undergoing intrauterine insemination.

Depuydt CE, Donders GGG, Verstraete L, Vanden Broeck D, Beert JFA, Salembier G, Bosmans E, Ombelet W.

Fertil Steril. 2019 Jun;111(6):1135-1144. doi: 10.1016/j.fertnstert.2019.02.002. Epub 2019 Apr 17.

PMID:
31005311
4.

Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.

de Bruyn A, Poesen K, Bossuyt X, Heremans IP, Claeys T, Depuydt CE, Van Damme P, Claeys KG.

Acta Neurol Belg. 2019 Mar;119(1):29-36. doi: 10.1007/s13760-019-01093-8. Epub 2019 Feb 12.

PMID:
30747336
5.

Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.

Depuydt CE, Beert J, Bosmans E, Salembier G.

Facts Views Vis Obgyn. 2016 Dec;8(4):211-222. Review.

6.

Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer.

Depuydt CE, Thys S, Beert J, Jonckheere J, Salembier G, Bogers JJ.

Int J Cancer. 2016 Nov 1;139(9):2021-32. doi: 10.1002/ijc.30238. Epub 2016 Jul 9.

7.
8.

Human Papillomavirus Positivity in Women Undergoing Intrauterine Insemination Has a Negative Effect on Pregnancy Rates.

Depuydt CE, Verstraete L, Berth M, Beert J, Bogers JP, Salembier G, Vereecken AJ, Bosmans E.

Gynecol Obstet Invest. 2016;81(1):41-6. doi: 10.1159/000434749. Epub 2015 Jul 9.

PMID:
26160018
9.

Laser micro-dissection and qPCR for identifying specific HPV types responsible for malignancy in penile lesions.

Lebelo RL, Thys S, Benoy I, Depuydt CE, Bogers JP, Bida MN, Mphahlele MJ.

J Med Virol. 2015 Oct;87(10):1761-8. doi: 10.1002/jmv.24229. Epub 2015 Jun 25.

PMID:
26112393
10.

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.

Depuydt CE, Jonckheere J, Berth M, Salembier GM, Vereecken AJ, Bogers JJ.

Cancer Med. 2015 Aug;4(8):1294-302. doi: 10.1002/cam4.473. Epub 2015 May 20.

11.

Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid.

Van Raemdonck GA, Tjalma WA, Coen EP, Depuydt CE, Van Ostade XW.

PLoS One. 2014 Sep 12;9(9):e106488. doi: 10.1371/journal.pone.0106488. eCollection 2014.

12.
13.

Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women.

Donders GG, Depuydt CE, Bogers JP, Vereecken AJ.

PLoS One. 2013 Dec 30;8(12):e86266. doi: 10.1371/journal.pone.0086266. eCollection 2013.

14.

Cervical cancer screening: which HPV test should be used--L1 or E6/E7?

Tjalma WA, Depuydt CE.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):45-6. doi: 10.1016/j.ejogrb.2013.06.027. Epub 2013 Aug 6.

PMID:
23932300
15.

Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas.

Duray A, Descamps G, Decaestecker C, Sirtaine N, Gilles A, Khalifé M, Chantrain G, Depuydt CE, Delvenne P, Saussez S.

Oncol Rep. 2013 Jul;30(1):371-6. doi: 10.3892/or.2013.2415. Epub 2013 Apr 22.

PMID:
23603900
16.

Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.

Depuydt CE, Benoy IH, Beert JF, Criel AM, Bogers JJ, Arbyn M.

J Clin Microbiol. 2012 Dec;50(12):4073-7. doi: 10.1128/JCM.01231-12. Epub 2012 Oct 10.

17.

Detection and quantification of human papillomavirus in benign and malignant parotid lesions.

Descamps G, Duray A, Rodriguez A, Chantrain G, Depuydt CE, Delvenne P, Saussez S.

Anticancer Res. 2012 Sep;32(9):3929-32.

PMID:
22993339
18.

Changes in type-specific human papillomavirus load predict progression to cervical cancer.

Depuydt CE, Criel AM, Benoy IH, Arbyn M, Vereecken AJ, Bogers JJ.

J Cell Mol Med. 2012 Dec;16(12):3096-104. doi: 10.1111/j.1582-4934.2012.01631.x.

19.

Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium.

D'Hauwers KW, Depuydt CE, Bogers JJ, Noel JC, Delvenne P, Marbaix E, Donders AR, Tjalma WA.

Vaccine. 2012 Oct 12;30(46):6573-7. doi: 10.1016/j.vaccine.2012.08.034. Epub 2012 Aug 30.

PMID:
22939906
20.

Anal human papillomavirus DNA in women at a colposcopy clinic.

D'Hauwers KW, Cornelissen T, Depuydt CE, Bogers J, Donders AR, Leuridan E, Van Damme P, Tjalma WA.

Eur J Obstet Gynecol Reprod Biol. 2012 Sep;164(1):69-73. doi: 10.1016/j.ejogrb.2012.05.014. Epub 2012 Jun 5.

PMID:
22677508

Supplemental Content

Loading ...
Support Center